Skip to content
Screener

Omnicell OMCL Net Change in Cash

Net Change in Cash at other companies

Baxter International logo
Baxter InternationalBAX
$51M+143%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$152M
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$800.32M+9,394%
Cardinal Health logo
Cardinal HealthCAH
$1.16B+340%
ICU Medical logo
ICU MedicalICUI
-$19.63M-4.1%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$24.77M-43.8%

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$68.3M+59.8%
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.65B+13.3%
Enterprise value$1.36B+27.3%
P/E35.3×
P/S1.3×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Excise tax paid on common stock repurchases(388)
Common stock repurchases(15,652)
Change in customer funds, net(23,923)3,307
Net cash used in financing activities(20,984)(7,431)
Effect of exchange rate changes on cash and cash equivalents(1,710)3,300
Net increase in cash, cash equivalents, and restricted cash71,72232,886
Cash, cash equivalents, and restricted cash at beginning of period251,032398,614
Cash, cash equivalents, and restricted cash at end of period$322,754$431,500

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's net change in cash?
Omnicell (OMCL) reported net change in cash of $31.79M in Q2 2026.
How has Omnicell's net change in cash changed year-over-year?
Omnicell's net change in cash increased by 85.9% year-over-year, from $17.1M to $31.79M.
What is the long-term trend for Omnicell's net change in cash?
Over 2 years (2021 to 2024), Omnicell's net change in cash has grown at a -12.7% compound annual growth rate (CAGR), from -$134.3M to -$102.37M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Omnicell's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude